Upon completion of the video presentation, to finish the activity and claim your credit, please click
here.
This activity has expired, credit is no longer available.
This activity is supported by an educational grant from Bristol-Myers Squibb.
Advances in Collaborative Practice for Patients with Head and Neck Cancers
Robert Haddad, MD
Dana-Farber Cancer Institute
Jason Glass, ACNP-BC
Dana-Farber Cancer Institute
Head and neck cancer care is complex, and there are limited treatment options; over the past decade only one new therapy received FDA approval. However, as in other tumor types, the landscape is changing with the recent emergence of newer targeted therapies and immunotherapies. This learning activity will provide advanced practitioners with valuable updates on screening and prevention, the risk associated with human papillomavirus (HPV), treatment options, mechanisms of action for new therapies, and monitoring for and the management of adverse events.
These CME/CE/CPE accredited activities are jointly provided by
